SMTL ID : 6vnl.4 (3 other biounits)

JAK2 JH1 in complex with SG3-179

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 2.40 Å

Oligo State

monomer

Ligands

1 x 5W2: 4-[[4-[[3-(~{tert}-butylsulfonylamino)-4-chloranyl-phenyl]amino]-5-methyl-pyrimidin-2-yl]amino]-2-fluoranyl-~{N}-(1-methylpiperidin-4-yl)benzamide(Non-covalent)

5W2.1: 16 residues within 4Å: Chain A: Q.30, L.31, G.32, K.33, G.34, V.39, A.56, V.87, M.105, E.106, Y.107, L.108, G.111, N.157, L.159, D.170 12 PLIP interactions: 12 interactions with chain A Hydrophobic interactions: A:L.31, A:L.31, A:V.39, A:V.39, A:A.56, A:V.87, A:M.105, A:Y.107, A:L.159 Hydrogen bonds: A:L.31, A:L.108, A:L.108

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Davis, R.R. et al., Structural Insights into JAK2 Inhibition by Ruxolitinib, Fedratinib, and Derivatives Thereof. J.Med.Chem. (2021)

Release Date

2021-02-17

Peptides

Tyrosine-protein kinase JAK2: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase JAK2

Related Entries With Identical Sequence